Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
AgroSpheres, Inc. is currently navigating 4 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 4 distinct examiners and 4 distinct art units, showing a diverse prosecution landscape. This distribution suggests that the company is pursuing multiple distinct technical paths or applications within its sector, rather than concentrating all efforts under a single reviewer or unit.
The busiest examiner in the portfolio is FAN, LYNN Y, who is responsible for 1 busiest examiner pending office action. While this examiner is the most active, they only handle a fraction of the total 4 pending office actions. This spread across different examiners and art units provides the company with multiple opportunities for portfolio growth, as the success of the overall strategy is not dependent on any single individual or art unit's specific tendencies.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 3 (75%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FAN, LYNN Y | 1 | 47.3% | +49.5% |
| LIU, SUE XU | 1 | 20.9% | +18.6% |
| PAK, JOHN D | 1 | 52.4% | +37.7% |
| YU, DAVID TUYANG | 1 | 100.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18257995 | COMPOSITIONS AND METHODS FOR CONTROLLING FUNGI | LIU, SUE XU | — |
| 17926069 | COMPOSITIONS AND METHODS FOR FUNGAL INHIBITION USING MINICELL-BASED RNAi | YU, DAVID TUYANG | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18594957 | COMPOSITIONS AND METHODS FOR THE ENCAPSULATION AND SCALABLE DELIVERY OF AGROCHEMICALS | FAN, LYNN Y | 15d |
| 18257995 | COMPOSITIONS AND METHODS FOR CONTROLLING FUNGI | LIU, SUE XU | — |
| 18037262 | BIOHERBICIDES FOR CONTROLLING ONE OR MORE PLANT SPECIES | PAK, JOHN D | — |
| Art Unit | Apps |
|---|---|
| 1759 | 1 |
| 1616 | 1 |
| 1699 | 1 |
| 1635 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18594957 | COMPOSITIONS AND METHODS FOR THE ENCAPSULATION AND SCALABLE DELIVERY OF AGROCHEMICALS | FAN, LYNN Y | 1759 | §102§103DP | Final Rejection | 15d | Pending | Mar 04, 2024 |
| 18257995 | COMPOSITIONS AND METHODS FOR CONTROLLING FUNGI | LIU, SUE XU | 1616 | §102§103§112DPOther | Non-Final OA | — | Pending | Jun 16, 2023 |
| 18037262 | BIOHERBICIDES FOR CONTROLLING ONE OR MORE PLANT SPECIES | PAK, JOHN D | 1699 | §103DP | Final Rejection | — | Pending | May 16, 2023 |
| 17926069 | COMPOSITIONS AND METHODS FOR FUNGAL INHIBITION USING MINICELL-BASED RNAi | YU, DAVID TUYANG | 1635 | §102§103§112 | Non-Final OA | — | Pending | Nov 17, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial